Immunotherapy in Lung Cancer
|Editors: ||Jianxing He, Jay M. Lee |
Publisher: AME Publishing Company; 1st edition (2023)
Hardcover: 364 pages
This book represents the culmination of the clinically relevant issues surrounding checkpoint inhibition and lung cancer. A panel of international expert authors are represented here and have contributed in the production of these seminal articles that concisely and accurately cover the broad topic of lung cancer immunotherapy. The content is categorized into immunotherapy and lung cancer, immunotherapy and early stage non-small cell lung cancer, immunotherapy and late stage non-small cell lung cancer, two expert consensus statements covering early and late stage non-small cell lung cancer, and immunotherapy and small cell lung cancer.
|Jianxing He ||Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, Guangzhou, China |
|Jay M. Lee ||Division of Thoracic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA |
|Toyoaki Hida ||Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan |